Asian men with metastatic PCa have superior ADT outcomes January 9, 2017 Among men with distant, de novo, metastatic prostate cancer (PCa) undergoing treatment with androgen-deprivation therapy (ADT), those of Asian ethnicity have superior median overall and PCa-specific survival to men of any other race, according to a study published in Cancer.Read more.Source: Cancer Therapy Advisor About Prostate Cancer Advanced Prostate Cancer Health Equity Prostate Cancer News More for you
Among men with distant, de novo, metastatic prostate cancer (PCa) undergoing treatment with androgen-deprivation therapy (ADT), those of Asian ethnicity have superior median overall and PCa-specific survival to men of any other race, according to a study published in Cancer.Read more.Source: Cancer Therapy Advisor
Complete the Survey
